Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Concurrent tunable structural color, luminescence, and afterglow in single ZnS: X@SiO2 spheres via SiO2-nanoarmor and calcination decoupling collaborative strategy.

Created on 25 Jul 2026

Authors

Tianyi Liu, Rou Meng, Shufen Zhang, Suli Wu

Published in

Smart molecules : open access. Pages e70065. Jun 24, 2026. Epub Jun 24, 2026.

Abstract

The integration of structural color, photoluminescence, and afterglow into a single material remains a fundamental challenge due to the conflicting requirements for structural integrity and high-temperature crystallization. Here, we present a SiO 2 -nanoarmor and calcination decoupling collaborative strategy to create monodisperse wurtzite-type ZnS: X@SiO2 spheres (X = Ag+, Cu2+, Mn2+) as a unified, single-particle optical platform. Spatially, a conformal SiO2 nanocoating acts as a thermally stable scaffold, preserving perfect spherical morphology during solid-phase transformation at 1000°C, thereby enabling angle-independent structural colors across the visible spectrum via Mie resonance. Calcination decoupling was achieved through an alternating O2/N2 atmosphere, which removes carbon deposits at low temperature and subsequently drives a complete sphalerite-to-wurtzite phase transition with 91% conversion, while preventing oxidation. Programmable doping introduces engineered energy levels, enabling tunable photoluminescence from 490 nm (blue) to 600 nm (orange) and white emission through co-doping. The fluorescence quantum yield was 12.8%. Notably, Cu- and Mn-doped spheres exhibit green afterglow lasting up to 12.27 s, and their duration was controlled by the content of the wurtzite phase. This intrinsic multifunctionality allows sophisticated multi-channel optical encryption, where a single pattern sequentially displays distinct information under natural light, UV illumination, and afterglow conditions.

PMID:
42500714
Bibliographic data and abstract were imported from PubMed on 25 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 16
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement